Detectability of Plasma-Derived Circulating Tumor DNA Panel in Patients Undergoing Primary Treatment for Uveal Melanoma

PURPOSE: To investigate the presence of plasma circulating tumor DNA (ctDNA) in patients with uveal melanoma during and after primary tumor treatment. METHODS: Detectability and variant allele frequency of ctDNA were assessed using a 129-oncogene panel using next-generation deep sequencing and hybri...

Descripción completa

Detalles Bibliográficos
Autores principales: Francis, Jasmine H., Barker, Christopher A., Brannon, A. Rose, Canestraro, Julia, Robbins, Melissa, Swartzwelder, Christina E., Levine, Sara, Law, Crystal, Berger, Michael F., Shoushtari, Alexander, Abramson, David H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2022
Materias:
Anatomy and Pathology/Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9766787/
https://www.ncbi.nlm.nih.gov/pubmed/36525262
http://dx.doi.org/10.1167/iovs.63.13.17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9766787/
https://www.ncbi.nlm.nih.gov/pubmed/36525262
http://dx.doi.org/10.1167/iovs.63.13.17

Ejemplares similares